about
Diagnostic and therapeutic challengesLocal methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.Teaching and assessing competency in retinal lasers in ophthalmology residency.Uveitis following intravitreal bevacizumab: a non-infectious cluster.A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel LociRetinal detachment in a patient with leber congenital amaurosis.Effect of internal limiting membrane abrasion on retinal tissues in macular holesLong-term outcomes in patients undergoing vitrectomy for retinal detachment due to viral retinitisUsing the Journal Club to teach and assess competence in practice-based learning and improvement: a literature review and recommendation for implementation.Preretinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in domestic pigs.Steroid-induced ptosis: case studies and histopathologic analysis.Teaching and assessing professionalism in ophthalmology residency training programs.The Iowa ophthalmology wet laboratory curriculum for teaching and assessing cataract surgical competency.Teaching and assessing systems-based competency in ophthalmology residency training programs.Re-engineering the resident applicant selection process in ophthalmology: a literature review and recommendations for improvement.Bilateral intravitreal injection of antivascular endothelial growth factor therapy.Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases.Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.Sequential, acute noninfectious uveitis associated with separate intravitreal injections of bevacizumab and ranibizumab.Consistency of observations from echograms made centrally in the Collaborative Ocular Melanoma Study COMS Report No. 13.Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts.Noninvasive in vivo detection of prognostic indicators for high-risk uveal melanoma: ultrasound parameter imaging.Comparison of microbiology and visual outcomes of patients undergoing small-gauge and 20-gauge vitrectomy for endophthalmitis.Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.Macular Hole Closure With Internal Limiting Membrane Abrasion Technique.The lowest effective dose of tissue plasminogen activator for fibrinolysis of postvitrectomy fibrin.Scleral buckle hemorrhagic cyst masquerading as an orbital tumor.Incomplete vitreomacular traction release using intravitreal ocriplasmin.Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy.Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.Diffuse anterior retinoblastoma without retinal involvement.Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy.Echographic evaluation of optic disc drusen.Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series.Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents.OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.A head-tilt test for hypopyon after intravitreal triamcinolone.Two non-infectious forms of endophthalmitis after intravitreal triamcinolone and cataract extraction.
P50
Q28219017-BF0A4CBF-D9B1-4F1C-93E2-18A646AB15EAQ30712188-A0ABF930-4416-49A9-B880-2DD8F382B3ECQ33362064-ADAEFC44-3CD5-473A-91E6-25235BCCF3A5Q33975229-58EC0417-053E-4EAA-8F72-39D3590BA3F9Q34639285-51CF620B-8962-4670-890E-F0618353275EQ35413766-ED6E3FB5-EE83-430C-8094-FC6BCC51EF07Q35560732-9C9AE357-82E4-4632-AC7E-BD93948AFF83Q35887340-040E23B2-EA0A-4A18-8CE8-441D8E43E955Q36303240-B68BDACC-B951-4DA1-A8AC-52CA2BDEDEFBQ36695627-B578657C-9153-42B6-8408-FFEC5B682D9AQ36707191-EB1E15F1-B400-468A-94CF-CB724BA34721Q36808162-7E3A9A50-E245-49D1-8F59-D2948571D3ACQ36809368-09D9B893-FE0D-4B6A-B41E-4ED7341AAF9BQ37009388-E4791DC7-C6DB-4D9D-9B36-B2E1236C8B97Q37113019-33BAA7FB-F94E-44D5-8F97-D2CD0E126A5CQ37824226-18A08658-1439-41A5-A806-970698650158Q37879437-5A2E223F-A3C0-4C10-9B86-F0D47CE1DC6FQ38065889-82B9EA56-5E88-42DA-A8FD-CD20513268AAQ38109282-E84B0AAE-6F93-46CD-BD05-DC0399DCBC4FQ38180920-A1B77E06-32C2-4BAF-AEF3-D5B8751F8993Q38266528-A8C3F4BB-4758-41CC-99DF-71513D85F76DQ38496488-E47D227A-CF17-4ADF-A807-A4EDF7A80554Q38964576-23CF8EB0-6701-4393-A5EE-E71CE141B785Q39678726-627C4615-BDAC-47A9-BD2D-3C1908BC9E4CQ40799208-B7BF75D3-AEA2-4F05-B3EA-10EC630622B3Q40868463-29D6BB52-C0D1-4690-9339-2550F760F06CQ41236927-764D2EAD-7344-4BBA-9297-CEDD83175ADFQ41825209-245662B9-70F8-4685-A23A-DAE0CF051B4CQ41894009-92B4A0C0-4726-4F06-9C9A-5A17A4DB137FQ42007511-D91160B2-02EC-44B4-891C-95759C350248Q42576555-986FD486-186A-4A37-BBB9-20C4AA626C5BQ42811750-CC9CFD83-41D9-4CAC-8EC0-DB1B8AC006D0Q42955603-99F38B39-6039-4258-ABB1-16411178BAFFQ44313042-E3C795AA-7A5C-4A6E-9654-1385A7B6AF31Q44906027-C3981F20-E180-4C8C-AB77-074AE7DBC36CQ45173859-91FA3431-AB7F-4C7F-A332-D80FF1681908Q45293401-341F042F-E742-4073-B06D-49358BAE3163Q45939532-DC8DD975-0045-4BC2-9972-BFE0C4DA7E08Q46192406-8F99DD21-8AEF-4B92-819C-FD48A1E0CB65Q46413338-0FFCEFB4-8459-4EE1-83AC-6D8C11D731A5
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7292-2093
@en
name
H. Culver Boldt
@ast
H. Culver Boldt
@en
H. Culver Boldt
@es
H. Culver Boldt
@nl
type
label
H. Culver Boldt
@ast
H. Culver Boldt
@en
H. Culver Boldt
@es
H. Culver Boldt
@nl
prefLabel
H. Culver Boldt
@ast
H. Culver Boldt
@en
H. Culver Boldt
@es
H. Culver Boldt
@nl
P106
P1153
7004515508
P31
P496
0000-0002-7292-2093